André Rudolph
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
André Rudolph has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Håkan Eliasson
Department of Pediatric Cardiology, Stockholm-Uppsala, Karolinska University Hospital , Stockholm
3 shared publications - Felicia Nordenstam
Pediatric Cardiology Unit, Department of Women's and Children's Health Karolinska Institutet, Karolinska University Hospital Stockholm Sweden
2 shared publications - Gunnar Bergman
Pediatric Cardiology Unit, Department of Women's and Children's Health Karolinska Institutet, Karolinska University Hospital Stockholm Sweden
2 shared publications - Johannes Mofors
Karolinska Institutet, Karolinska University Hospital
2 shared publications - Marie Wahren-Herlenius
Division of Rheumatology, Department of Medicine, Karolinska Institutet , Stockholm
2 shared publications A Frisk
Karolinska Institutet, Karolinska University Hospital
1 shared publication
Latest Publications
- Open Access
- 15 July 2026
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- p. 1-9
Patterns of migration underlie the increasing incidence of Kawasaki disease in Sweden from 1987 to 2018: a cohort study
To define the demographics of Kawasaki disease (KD) in Sweden during a 32 year period. Routinely collected administrative and healthcare data from nationwide Swedish registers were collected for this population-based cohort study. The case definition was individuals under the age of 25 and diagnosed with KD from 1987 to 2018. Main measures included incidence rate, year and month of diagnosis, sex and age at diagnosis, patient's and parents' world region of birth, and home county. In total, 1917 cases were identified. Median age at diagnosis was 2.82 years (interquartile range 1.47-5.13) and 62% were males. Relative incidence rates in winter [1.29, 95% confidence interval (CI) 1.14-1.47] and spring (1.21, 95% CI 1.07-1.38) were higher than in the reference season (summer), while incidence over the study period varied geographically across counties, with no discernible pattern. The incidence rate in the population increased during the 32 year period from 3.6 to 12.1 (95% CI 9.1-15.2) per 100 000 under-5-year-olds during the last 5 years of the study. This increase related mainly to cases with one or two parents of non-Swedish, predominantly Asian and African, origin. Two significant peaks in incidence rates in 2008 and 2015 were also observed, mainly relating to cases with two Swedish-born parents. Our study confirms the age and sex distribution as well as seasonal variation and occurrence of peak years of KD. Migration patterns were associated with increasing numbers of KD, which is important to consider for healthcare planning and for defining risk groups.
- 15 July 2026
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- p. 1-9
Open AccessPatterns of migration underlie the increasing incidence of Kawasaki disease in Sweden from 1987 to 2018: a cohort study
To define the demographics of Kawasaki disease (KD) in Sweden during a 32 year period. Routinely collected administrative and healthcare data from nationwide Swedish registers were collected for this population-based cohort study. The case definition was individuals under the age of 25 and diagnosed with KD from 1987 to 2018. Main measures included incidence rate, year and month of diagnosis, sex and age at diagnosis, patient's and parents' world region of birth, and home county. In total, 1917 cases were identified. Median age at diagnosis was 2.82 years (interquartile range 1.47-5.13) and 62% were males. Relative incidence rates in winter [1.29, 95% confidence interval (CI) 1.14-1.47] and spring (1.21, 95% CI 1.07-1.38) were higher than in the reference season (summer), while incidence over the study period varied geographically across counties, with no discernible pattern. The incidence rate in the population increased during the 32 year period from 3.6 to 12.1 (95% CI 9.1-15.2) per 100 000 under-5-year-olds during the last 5 years of the study. This increase related mainly to cases with one or two parents of non-Swedish, predominantly Asian and African, origin. Two significant peaks in incidence rates in 2008 and 2015 were also observed, mainly relating to cases with two Swedish-born parents. Our study confirms the age and sex distribution as well as seasonal variation and occurrence of peak years of KD. Migration patterns were associated with increasing numbers of KD, which is important to consider for healthcare planning and for defining risk groups.
- Open Access
- 11 December 2025
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (1)
Outcomes for patients implanted with a cardioverter-defibrillator at <19 years of age: a Swedish national study
Aims: To explore the prevalence and incidence of paediatric implantable cardioverter-defibrillator (ICD) patients in Sweden and identify risk factors associated with appropriate shocks and adverse events. Methods and results: We performed a nationwide, retrospective cohort study of ICD use in paediatric patients (<19 years) between 1995 and 2017; 120 patients underwent ICD implantation at median age 14.7 (range 1.1–18.9) years and were followed for 7.1 (0.3–20.4) years. Fifty-four patients (45%) received a primary preventive ICD; 46% had cardiomyopathy, and 41% had primary electrical disease. The estimated 5-year survival without appropriate shocks was 68% (confidence interval 59–78). Secondary preventive ICDs and lower weight (<30 kg) at implantation were associated with a higher rate of appropriate shocks, respectively. Lower weight at implantation was not a risk factor for adverse events. Inadequate medication and insufficient compliance were common in patients who experienced shocks. Less than half (46%) of the cases with inappropriate shocks were adequately medicated with good compliance. Secondly, an incidence and prevalence study of all paediatric and adult patients who had an ICD implanted in Sweden was analysed in 4-year periods between 2002 and 2021. The incidence of paediatric ICD implantations in Sweden peaked at 0.56 per 100 000 person-years in 2010–13, decreasing to 0.45 per 100 000 person-years in the last study period (2018–21). Conclusion: Appropriate shocks were more than twice as common in the youngest patient group, whereas adverse events were not more frequent than in the older patient group. Inadequate medication and lack of compliance were common in connection with ICD shocks.
- 11 December 2025
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (1)
Open AccessOutcomes for patients implanted with a cardioverter-defibrillator at <19 years of age: a Swedish national study
Aims: To explore the prevalence and incidence of paediatric implantable cardioverter-defibrillator (ICD) patients in Sweden and identify risk factors associated with appropriate shocks and adverse events. Methods and results: We performed a nationwide, retrospective cohort study of ICD use in paediatric patients (<19 years) between 1995 and 2017; 120 patients underwent ICD implantation at median age 14.7 (range 1.1–18.9) years and were followed for 7.1 (0.3–20.4) years. Fifty-four patients (45%) received a primary preventive ICD; 46% had cardiomyopathy, and 41% had primary electrical disease. The estimated 5-year survival without appropriate shocks was 68% (confidence interval 59–78). Secondary preventive ICDs and lower weight (<30 kg) at implantation were associated with a higher rate of appropriate shocks, respectively. Lower weight at implantation was not a risk factor for adverse events. Inadequate medication and insufficient compliance were common in patients who experienced shocks. Less than half (46%) of the cases with inappropriate shocks were adequately medicated with good compliance. Secondly, an incidence and prevalence study of all paediatric and adult patients who had an ICD implanted in Sweden was analysed in 4-year periods between 2002 and 2021. The incidence of paediatric ICD implantations in Sweden peaked at 0.56 per 100 000 person-years in 2010–13, decreasing to 0.45 per 100 000 person-years in the last study period (2018–21). Conclusion: Appropriate shocks were more than twice as common in the youngest patient group, whereas adverse events were not more frequent than in the older patient group. Inadequate medication and lack of compliance were common in connection with ICD shocks.
- Open Access
- 22 October 2025
- Published by Karolinska Institutet
Epidemiologic studies on Kawasaki disease during 30 years in Sweden
Kawasaki disease (KD) is a paediatric vasculitis that presents with fever, affecting mostly medium-sized arteries. Inflammation is visible in the skin, eyes, mouth, and lymph nodes, while other organs such as the gastrointestinal tract and the nervous system can also be involved. KD develops dependent on genetic susceptibility in combination with certain, yet unknown triggers. Untreated, it leads to coronary artery aneurysms (CAA) in a quarter of affected children with a risk for myocardial infarction in the acute or chronic phase.Incidence rates are significantly higher in Asian populations than elsewhere in the world. For the Nordic population, the last comprehensive study of KD at a national level was performed in 2013. The overall aim of this thesis was therefore to characterize the epidemiologic features of KD in a Nordic population over a long period of time from different perspectives. With data from the Swedish national healthcare registers, we developed a dataset to study KD over 32 years in the Swedish population. We found that the incidence rate of KD rose steadily prior to the SARS-CoV-2 pandemic, with certain peak years and an increasing percentage of children that are born outside Sweden themselves, or with parents born outside Sweden. We concluded that migration patterns may be associated with generally increasing numbers of KD.As we used register data for KD with previously unvalidated diagnostic codes, we performed a validation study of the clinical diagnosis of KD based on the medical records. We found a 95% concordance between the registered KD diagnosis and the medical records in relation to international KD criteria. We thus concluded that the validity of a KD diagnosis in our national registers is high with high specificity. These data are therefore reliable both for studies of risk factors for KD and future epidemiological research. When examining clinical care data, we observed that treatment guidelines were followed, and that outcomes were usually favourable.In our population, we also wanted to identify risk factors for KD. First, we performed a case-control study to investigate if a history of infection associated with a higher risk of developing KD. We found that children who later developed KD already have a higher rate of diagnoses of infections from birth than controls, not just directly before KD.In a second case-control study, we investigated perinatal risk factors. We found that prematurity was a significant risk factor for developing KD. In addition, prenatal maternal smoking, advanced maternal age, and Asian or African descent were also found to be risk factors.For the clinician, it is important to know the extent of CAA so that diagnostics and treatment are precise. As Sweden only has low numbers of children with CAA that underwent detailed imaging by cardiac catheterization, we developed a comparative study of the prevalence and morphology of CAA in a mixed European population. We found that distal CAAs were almost exclusively detected alongside proximal CAAs. Thus, distal CAA are not likely to be missed with standard diagnostic technique, helping to avoid unnecessary interventions.In conclusion, this thesis adds to the current understanding of epidemiologic and clinical factors in Kawasaki disease.List of scientific papersI. Patterns of migration underlie changing epidemiology of Kawasaki disease outside of Covid-19: a cohort study. Rudolph A, Mofors J, Frisk A, Schiller B, Elinder G, Nordenstam F, Eliasson H, Bergman G, Granath F, Wahren-Herlenius M. [Submitted]II. Clinical features and treatment of Kawasaki disease in validated cases in the Swedish National Patient Register. Rudolph A, Mofors J, Eliasson H, Bergman G, Wahren-Herlenius M. [Manuscript]III. Associations of infection burden with Kawasaki disease in a population-based setting during 30 years. Mofors J, Rudolph A, Schiller B, Elinder G, Sonesson SE, Eliasson H, Bergman G, Wahren-Herlenius M. RMD Open 2025;11:e005160. https://doi.org/10.1136/rmdopen-2024-005160IV. Swedish nationwide study found that prematurity was associated with Kawasaki disease. Frisk A, Rudolph A, Eliasson H, Nordenstam F, Bergman G, Wahren-Herlenius M, Mofors J. Acta Paediatrica, 2025; 0:1-10. https://doi.org/10.1111/apa.70071V. Specific morphology of coronary artery aneurysms in mainly white patients with Kawasaki disease: Initial data from the cardiac catheterization in Kawasaki disease registry. Weisser J, Arnold L, Wällisch W, Quandt D, Opgen-Rhein B, Riede FT, Gräfe F, Michel J, Arnold R, Schneider H, Tanase D, Herberg U, Happel C, Tietje M, Tarusinov G, Grohmann J, Hummel J, Rudolph A, Haas N, Jakob A. J Am Heart Assoc. 2024;13:e034248. https://doi.org/10.1161/JAHA.124.034248
- 22 October 2025
- Published by Karolinska Institutet
Open AccessEpidemiologic studies on Kawasaki disease during 30 years in Sweden
Kawasaki disease (KD) is a paediatric vasculitis that presents with fever, affecting mostly medium-sized arteries. Inflammation is visible in the skin, eyes, mouth, and lymph nodes, while other organs such as the gastrointestinal tract and the nervous system can also be involved. KD develops dependent on genetic susceptibility in combination with certain, yet unknown triggers. Untreated, it leads to coronary artery aneurysms (CAA) in a quarter of affected children with a risk for myocardial infarction in the acute or chronic phase.Incidence rates are significantly higher in Asian populations than elsewhere in the world. For the Nordic population, the last comprehensive study of KD at a national level was performed in 2013. The overall aim of this thesis was therefore to characterize the epidemiologic features of KD in a Nordic population over a long period of time from different perspectives. With data from the Swedish national healthcare registers, we developed a dataset to study KD over 32 years in the Swedish population. We found that the incidence rate of KD rose steadily prior to the SARS-CoV-2 pandemic, with certain peak years and an increasing percentage of children that are born outside Sweden themselves, or with parents born outside Sweden. We concluded that migration patterns may be associated with generally increasing numbers of KD.As we used register data for KD with previously unvalidated diagnostic codes, we performed a validation study of the clinical diagnosis of KD based on the medical records. We found a 95% concordance between the registered KD diagnosis and the medical records in relation to international KD criteria. We thus concluded that the validity of a KD diagnosis in our national registers is high with high specificity. These data are therefore reliable both for studies of risk factors for KD and future epidemiological research. When examining clinical care data, we observed that treatment guidelines were followed, and that outcomes were usually favourable.In our population, we also wanted to identify risk factors for KD. First, we performed a case-control study to investigate if a history of infection associated with a higher risk of developing KD. We found that children who later developed KD already have a higher rate of diagnoses of infections from birth than controls, not just directly before KD.In a second case-control study, we investigated perinatal risk factors. We found that prematurity was a significant risk factor for developing KD. In addition, prenatal maternal smoking, advanced maternal age, and Asian or African descent were also found to be risk factors.For the clinician, it is important to know the extent of CAA so that diagnostics and treatment are precise. As Sweden only has low numbers of children with CAA that underwent detailed imaging by cardiac catheterization, we developed a comparative study of the prevalence and morphology of CAA in a mixed European population. We found that distal CAAs were almost exclusively detected alongside proximal CAAs. Thus, distal CAA are not likely to be missed with standard diagnostic technique, helping to avoid unnecessary interventions.In conclusion, this thesis adds to the current understanding of epidemiologic and clinical factors in Kawasaki disease.List of scientific papersI. Patterns of migration underlie changing epidemiology of Kawasaki disease outside of Covid-19: a cohort study. Rudolph A, Mofors J, Frisk A, Schiller B, Elinder G, Nordenstam F, Eliasson H, Bergman G, Granath F, Wahren-Herlenius M. [Submitted]II. Clinical features and treatment of Kawasaki disease in validated cases in the Swedish National Patient Register. Rudolph A, Mofors J, Eliasson H, Bergman G, Wahren-Herlenius M. [Manuscript]III. Associations of infection burden with Kawasaki disease in a population-based setting during 30 years. Mofors J, Rudolph A, Schiller B, Elinder G, Sonesson SE, Eliasson H, Bergman G, Wahren-Herlenius M. RMD Open 2025;11:e005160. https://doi.org/10.1136/rmdopen-2024-005160IV. Swedish nationwide study found that prematurity was associated with Kawasaki disease. Frisk A, Rudolph A, Eliasson H, Nordenstam F, Bergman G, Wahren-Herlenius M, Mofors J. Acta Paediatrica, 2025; 0:1-10. https://doi.org/10.1111/apa.70071V. Specific morphology of coronary artery aneurysms in mainly white patients with Kawasaki disease: Initial data from the cardiac catheterization in Kawasaki disease registry. Weisser J, Arnold L, Wällisch W, Quandt D, Opgen-Rhein B, Riede FT, Gräfe F, Michel J, Arnold R, Schneider H, Tanase D, Herberg U, Happel C, Tietje M, Tarusinov G, Grohmann J, Hummel J, Rudolph A, Haas N, Jakob A. J Am Heart Assoc. 2024;13:e034248. https://doi.org/10.1161/JAHA.124.034248
- Open Access
- 22 October 2025
- Published by Karolinska Institutet
Epidemiologic studies on Kawasaki disease during 30 years in Sweden
Kawasaki disease (KD) is a paediatric vasculitis that presents with fever, affecting mostly medium-sized arteries. Inflammation is visible in the skin, eyes, mouth, and lymph nodes, while other organs such as the gastrointestinal tract and the nervous system can also be involved. KD develops dependent on genetic susceptibility in combination with certain, yet unknown triggers. Untreated, it leads to coronary artery aneurysms (CAA) in a quarter of affected children with a risk for myocardial infarction in the acute or chronic phase.Incidence rates are significantly higher in Asian populations than elsewhere in the world. For the Nordic population, the last comprehensive study of KD at a national level was performed in 2013. The overall aim of this thesis was therefore to characterize the epidemiologic features of KD in a Nordic population over a long period of time from different perspectives. With data from the Swedish national healthcare registers, we developed a dataset to study KD over 32 years in the Swedish population. We found that the incidence rate of KD rose steadily prior to the SARS-CoV-2 pandemic, with certain peak years and an increasing percentage of children that are born outside Sweden themselves, or with parents born outside Sweden. We concluded that migration patterns may be associated with generally increasing numbers of KD.As we used register data for KD with previously unvalidated diagnostic codes, we performed a validation study of the clinical diagnosis of KD based on the medical records. We found a 95% concordance between the registered KD diagnosis and the medical records in relation to international KD criteria. We thus concluded that the validity of a KD diagnosis in our national registers is high with high specificity. These data are therefore reliable both for studies of risk factors for KD and future epidemiological research. When examining clinical care data, we observed that treatment guidelines were followed, and that outcomes were usually favourable.In our population, we also wanted to identify risk factors for KD. First, we performed a case-control study to investigate if a history of infection associated with a higher risk of developing KD. We found that children who later developed KD already have a higher rate of diagnoses of infections from birth than controls, not just directly before KD.In a second case-control study, we investigated perinatal risk factors. We found that prematurity was a significant risk factor for developing KD. In addition, prenatal maternal smoking, advanced maternal age, and Asian or African descent were also found to be risk factors.For the clinician, it is important to know the extent of CAA so that diagnostics and treatment are precise. As Sweden only has low numbers of children with CAA that underwent detailed imaging by cardiac catheterization, we developed a comparative study of the prevalence and morphology of CAA in a mixed European population. We found that distal CAAs were almost exclusively detected alongside proximal CAAs. Thus, distal CAA are not likely to be missed with standard diagnostic technique, helping to avoid unnecessary interventions.In conclusion, this thesis adds to the current understanding of epidemiologic and clinical factors in Kawasaki disease.List of scientific papersI. Patterns of migration underlie changing epidemiology of Kawasaki disease outside of Covid-19: a cohort study. Rudolph A, Mofors J, Frisk A, Schiller B, Elinder G, Nordenstam F, Eliasson H, Bergman G, Granath F, Wahren-Herlenius M. [Submitted]II. Clinical features and treatment of Kawasaki disease in validated cases in the Swedish National Patient Register. Rudolph A, Mofors J, Eliasson H, Bergman G, Wahren-Herlenius M. [Manuscript]III. Associations of infection burden with Kawasaki disease in a population-based setting during 30 years. Mofors J, Rudolph A, Schiller B, Elinder G, Sonesson SE, Eliasson H, Bergman G, Wahren-Herlenius M. RMD Open 2025;11:e005160. https://doi.org/10.1136/rmdopen-2024-005160IV. Swedish nationwide study found that prematurity was associated with Kawasaki disease. Frisk A, Rudolph A, Eliasson H, Nordenstam F, Bergman G, Wahren-Herlenius M, Mofors J. Acta Paediatrica, 2025; 0:1-10. https://doi.org/10.1111/apa.70071V. Specific morphology of coronary artery aneurysms in mainly white patients with Kawasaki disease: Initial data from the cardiac catheterization in Kawasaki disease registry. Weisser J, Arnold L, Wällisch W, Quandt D, Opgen-Rhein B, Riede FT, Gräfe F, Michel J, Arnold R, Schneider H, Tanase D, Herberg U, Happel C, Tietje M, Tarusinov G, Grohmann J, Hummel J, Rudolph A, Haas N, Jakob A. J Am Heart Assoc. 2024;13:e034248. https://doi.org/10.1161/JAHA.124.034248
- 22 October 2025
- Published by Karolinska Institutet
Open AccessEpidemiologic studies on Kawasaki disease during 30 years in Sweden
Kawasaki disease (KD) is a paediatric vasculitis that presents with fever, affecting mostly medium-sized arteries. Inflammation is visible in the skin, eyes, mouth, and lymph nodes, while other organs such as the gastrointestinal tract and the nervous system can also be involved. KD develops dependent on genetic susceptibility in combination with certain, yet unknown triggers. Untreated, it leads to coronary artery aneurysms (CAA) in a quarter of affected children with a risk for myocardial infarction in the acute or chronic phase.Incidence rates are significantly higher in Asian populations than elsewhere in the world. For the Nordic population, the last comprehensive study of KD at a national level was performed in 2013. The overall aim of this thesis was therefore to characterize the epidemiologic features of KD in a Nordic population over a long period of time from different perspectives. With data from the Swedish national healthcare registers, we developed a dataset to study KD over 32 years in the Swedish population. We found that the incidence rate of KD rose steadily prior to the SARS-CoV-2 pandemic, with certain peak years and an increasing percentage of children that are born outside Sweden themselves, or with parents born outside Sweden. We concluded that migration patterns may be associated with generally increasing numbers of KD.As we used register data for KD with previously unvalidated diagnostic codes, we performed a validation study of the clinical diagnosis of KD based on the medical records. We found a 95% concordance between the registered KD diagnosis and the medical records in relation to international KD criteria. We thus concluded that the validity of a KD diagnosis in our national registers is high with high specificity. These data are therefore reliable both for studies of risk factors for KD and future epidemiological research. When examining clinical care data, we observed that treatment guidelines were followed, and that outcomes were usually favourable.In our population, we also wanted to identify risk factors for KD. First, we performed a case-control study to investigate if a history of infection associated with a higher risk of developing KD. We found that children who later developed KD already have a higher rate of diagnoses of infections from birth than controls, not just directly before KD.In a second case-control study, we investigated perinatal risk factors. We found that prematurity was a significant risk factor for developing KD. In addition, prenatal maternal smoking, advanced maternal age, and Asian or African descent were also found to be risk factors.For the clinician, it is important to know the extent of CAA so that diagnostics and treatment are precise. As Sweden only has low numbers of children with CAA that underwent detailed imaging by cardiac catheterization, we developed a comparative study of the prevalence and morphology of CAA in a mixed European population. We found that distal CAAs were almost exclusively detected alongside proximal CAAs. Thus, distal CAA are not likely to be missed with standard diagnostic technique, helping to avoid unnecessary interventions.In conclusion, this thesis adds to the current understanding of epidemiologic and clinical factors in Kawasaki disease.List of scientific papersI. Patterns of migration underlie changing epidemiology of Kawasaki disease outside of Covid-19: a cohort study. Rudolph A, Mofors J, Frisk A, Schiller B, Elinder G, Nordenstam F, Eliasson H, Bergman G, Granath F, Wahren-Herlenius M. [Submitted]II. Clinical features and treatment of Kawasaki disease in validated cases in the Swedish National Patient Register. Rudolph A, Mofors J, Eliasson H, Bergman G, Wahren-Herlenius M. [Manuscript]III. Associations of infection burden with Kawasaki disease in a population-based setting during 30 years. Mofors J, Rudolph A, Schiller B, Elinder G, Sonesson SE, Eliasson H, Bergman G, Wahren-Herlenius M. RMD Open 2025;11:e005160. https://doi.org/10.1136/rmdopen-2024-005160IV. Swedish nationwide study found that prematurity was associated with Kawasaki disease. Frisk A, Rudolph A, Eliasson H, Nordenstam F, Bergman G, Wahren-Herlenius M, Mofors J. Acta Paediatrica, 2025; 0:1-10. https://doi.org/10.1111/apa.70071V. Specific morphology of coronary artery aneurysms in mainly white patients with Kawasaki disease: Initial data from the cardiac catheterization in Kawasaki disease registry. Weisser J, Arnold L, Wällisch W, Quandt D, Opgen-Rhein B, Riede FT, Gräfe F, Michel J, Arnold R, Schneider H, Tanase D, Herberg U, Happel C, Tietje M, Tarusinov G, Grohmann J, Hummel J, Rudolph A, Haas N, Jakob A. J Am Heart Assoc. 2024;13:e034248. https://doi.org/10.1161/JAHA.124.034248
- Open Access
- 23 September 2025
- Published by Karolinska Institutet
Epidemiologic studies on Kawasaki disease during 30 years in Sweden
Kawasaki disease (KD) is a paediatric vasculitis that presents with fever, affecting mostly medium-sized arteries. Inflammation is visible in the skin, eyes, mouth, and lymph nodes, while other organs such as the gastrointestinal tract and the nervous system can also be involved. KD develops dependent on genetic susceptibility in combination with certain, yet unknown triggers. Untreated, it leads to coronary artery aneurysms (CAA) in a quarter of affected children with a risk for myocardial infarction in the acute or chronic phase.Incidence rates are significantly higher in Asian populations than elsewhere in the world. For the Nordic population, the last comprehensive study of KD at a national level was performed in 2013. The overall aim of this thesis was therefore to characterize the epidemiologic features of KD in a Nordic population over a long period of time from different perspectives. With data from the Swedish national healthcare registers, we developed a dataset to study KD over 32 years in the Swedish population. We found that the incidence rate of KD rose steadily prior to the SARS-CoV-2 pandemic, with certain peak years and an increasing percentage of children that are born outside Sweden themselves, or with parents born outside Sweden. We concluded that migration patterns may be associated with generally increasing numbers of KD.As we used register data for KD with previously unvalidated diagnostic codes, we performed a validation study of the clinical diagnosis of KD based on the medical records. We found a 95% concordance between the registered KD diagnosis and the medical records in relation to international KD criteria. We thus concluded that the validity of a KD diagnosis in our national registers is high with high specificity. These data are therefore reliable both for studies of risk factors for KD and future epidemiological research. When examining clinical care data, we observed that treatment guidelines were followed, and that outcomes were usually favourable.In our population, we also wanted to identify risk factors for KD. First, we performed a case-control study to investigate if a history of infection associated with a higher risk of developing KD. We found that children who later developed KD already have a higher rate of diagnoses of infections from birth than controls, not just directly before KD.In a second case-control study, we investigated perinatal risk factors. We found that prematurity was a significant risk factor for developing KD. In addition, prenatal maternal smoking, advanced maternal age, and Asian or African descent were also found to be risk factors.For the clinician, it is important to know the extent of CAA so that diagnostics and treatment are precise. As Sweden only has low numbers of children with CAA that underwent detailed imaging by cardiac catheterization, we developed a comparative study of the prevalence and morphology of CAA in a mixed European population. We found that distal CAAs were almost exclusively detected alongside proximal CAAs. Thus, distal CAA are not likely to be missed with standard diagnostic technique, helping to avoid unnecessary interventions.In conclusion, this thesis adds to the current understanding of epidemiologic and clinical factors in Kawasaki disease.List of scientific papersI. Patterns of migration underlie changing epidemiology of Kawasaki disease outside of Covid-19: a cohort study. Rudolph A, Mofors J, Frisk A, Schiller B, Elinder G, Nordenstam F, Eliasson H, Bergman G, Granath F, Wahren-Herlenius M. [Submitted]II. Clinical features and treatment of Kawasaki disease in validated cases in the Swedish National Patient Register. Rudolph A, Mofors J, Eliasson H, Bergman G, Wahren-Herlenius M. [Manuscript]III. Associations of infection burden with Kawasaki disease in a population-based setting during 30 years. Mofors J, Rudolph A, Schiller B, Elinder G, Sonesson SE, Eliasson H, Bergman G, Wahren-Herlenius M. RMD Open 2025;11:e005160. https://doi.org/10.1136/rmdopen-2024-005160IV. Swedish nationwide study found that prematurity was associated with Kawasaki disease. Frisk A, Rudolph A, Eliasson H, Nordenstam F, Bergman G, Wahren-Herlenius M, Mofors J. Acta Paediatrica, 2025; 0:1-10. https://doi.org/10.1111/apa.70071V. Specific morphology of coronary artery aneurysms in mainly white patients with Kawasaki disease: Initial data from the cardiac catheterization in Kawasaki disease registry. Weisser J, Arnold L, Wällisch W, Quandt D, Opgen-Rhein B, Riede FT, Gräfe F, Michel J, Arnold R, Schneider H, Tanase D, Herberg U, Happel C, Tietje M, Tarusinov G, Grohmann J, Hummel J, Rudolph A, Haas N, Jakob A. J Am Heart Assoc. 2024;13:e034248. https://doi.org/10.1161/JAHA.124.034248
- 23 September 2025
- Published by Karolinska Institutet
Open AccessEpidemiologic studies on Kawasaki disease during 30 years in Sweden
Kawasaki disease (KD) is a paediatric vasculitis that presents with fever, affecting mostly medium-sized arteries. Inflammation is visible in the skin, eyes, mouth, and lymph nodes, while other organs such as the gastrointestinal tract and the nervous system can also be involved. KD develops dependent on genetic susceptibility in combination with certain, yet unknown triggers. Untreated, it leads to coronary artery aneurysms (CAA) in a quarter of affected children with a risk for myocardial infarction in the acute or chronic phase.Incidence rates are significantly higher in Asian populations than elsewhere in the world. For the Nordic population, the last comprehensive study of KD at a national level was performed in 2013. The overall aim of this thesis was therefore to characterize the epidemiologic features of KD in a Nordic population over a long period of time from different perspectives. With data from the Swedish national healthcare registers, we developed a dataset to study KD over 32 years in the Swedish population. We found that the incidence rate of KD rose steadily prior to the SARS-CoV-2 pandemic, with certain peak years and an increasing percentage of children that are born outside Sweden themselves, or with parents born outside Sweden. We concluded that migration patterns may be associated with generally increasing numbers of KD.As we used register data for KD with previously unvalidated diagnostic codes, we performed a validation study of the clinical diagnosis of KD based on the medical records. We found a 95% concordance between the registered KD diagnosis and the medical records in relation to international KD criteria. We thus concluded that the validity of a KD diagnosis in our national registers is high with high specificity. These data are therefore reliable both for studies of risk factors for KD and future epidemiological research. When examining clinical care data, we observed that treatment guidelines were followed, and that outcomes were usually favourable.In our population, we also wanted to identify risk factors for KD. First, we performed a case-control study to investigate if a history of infection associated with a higher risk of developing KD. We found that children who later developed KD already have a higher rate of diagnoses of infections from birth than controls, not just directly before KD.In a second case-control study, we investigated perinatal risk factors. We found that prematurity was a significant risk factor for developing KD. In addition, prenatal maternal smoking, advanced maternal age, and Asian or African descent were also found to be risk factors.For the clinician, it is important to know the extent of CAA so that diagnostics and treatment are precise. As Sweden only has low numbers of children with CAA that underwent detailed imaging by cardiac catheterization, we developed a comparative study of the prevalence and morphology of CAA in a mixed European population. We found that distal CAAs were almost exclusively detected alongside proximal CAAs. Thus, distal CAA are not likely to be missed with standard diagnostic technique, helping to avoid unnecessary interventions.In conclusion, this thesis adds to the current understanding of epidemiologic and clinical factors in Kawasaki disease.List of scientific papersI. Patterns of migration underlie changing epidemiology of Kawasaki disease outside of Covid-19: a cohort study. Rudolph A, Mofors J, Frisk A, Schiller B, Elinder G, Nordenstam F, Eliasson H, Bergman G, Granath F, Wahren-Herlenius M. [Submitted]II. Clinical features and treatment of Kawasaki disease in validated cases in the Swedish National Patient Register. Rudolph A, Mofors J, Eliasson H, Bergman G, Wahren-Herlenius M. [Manuscript]III. Associations of infection burden with Kawasaki disease in a population-based setting during 30 years. Mofors J, Rudolph A, Schiller B, Elinder G, Sonesson SE, Eliasson H, Bergman G, Wahren-Herlenius M. RMD Open 2025;11:e005160. https://doi.org/10.1136/rmdopen-2024-005160IV. Swedish nationwide study found that prematurity was associated with Kawasaki disease. Frisk A, Rudolph A, Eliasson H, Nordenstam F, Bergman G, Wahren-Herlenius M, Mofors J. Acta Paediatrica, 2025; 0:1-10. https://doi.org/10.1111/apa.70071V. Specific morphology of coronary artery aneurysms in mainly white patients with Kawasaki disease: Initial data from the cardiac catheterization in Kawasaki disease registry. Weisser J, Arnold L, Wällisch W, Quandt D, Opgen-Rhein B, Riede FT, Gräfe F, Michel J, Arnold R, Schneider H, Tanase D, Herberg U, Happel C, Tietje M, Tarusinov G, Grohmann J, Hummel J, Rudolph A, Haas N, Jakob A. J Am Heart Assoc. 2024;13:e034248. https://doi.org/10.1161/JAHA.124.034248
- Open Access
- 28 March 2025
- Published by Wiley in Acta Paediatrica
- Vol. 114 (8) , 1990-1999
Swedish Nationwide Study Found That Prematurity Was Associated With Kawasaki Disease
Aim: Our aim was to identify perinatal and parental risk factors for Kawasaki disease (KD). Methods: Swedish patient and population registers were used to identify children diagnosed with KD and unaffected matched controls from 1987 to 2018. Logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CI) following exposure to perinatal and parental factors. Results: We identified 1645 cases (61% male) and 15 463 matched controls. The median age of KD diagnoses was 2.6 years. Preterm birth was significantly associated with increased odds of developing KD (OR 1.24, 95% CI 1.01–1.53), particularly for children diagnosed before 1 year of age (OR 1.82, 95% CI 1.15–2.86). Prenatal maternal smoking was also associated with diagnoses before 1 year of age and the risk was increased in males if their mothers were 35 years of age or older at the time of delivery. The risk was higher among children of Asian or African descent. Perinatal factors had a higher impact on the risk of KD in children with Asian parents. Conclusion: Prematurity was significantly associated with an increased risk of developing KD. Other risks were prenatal maternal smoking, advanced maternal age, and being of Asian or African descent.
- 28 March 2025
- Published by Wiley in Acta Paediatrica
- Vol. 114 (8) , 1990-1999
Open AccessSwedish Nationwide Study Found That Prematurity Was Associated With Kawasaki Disease
Aim: Our aim was to identify perinatal and parental risk factors for Kawasaki disease (KD). Methods: Swedish patient and population registers were used to identify children diagnosed with KD and unaffected matched controls from 1987 to 2018. Logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CI) following exposure to perinatal and parental factors. Results: We identified 1645 cases (61% male) and 15 463 matched controls. The median age of KD diagnoses was 2.6 years. Preterm birth was significantly associated with increased odds of developing KD (OR 1.24, 95% CI 1.01–1.53), particularly for children diagnosed before 1 year of age (OR 1.82, 95% CI 1.15–2.86). Prenatal maternal smoking was also associated with diagnoses before 1 year of age and the risk was increased in males if their mothers were 35 years of age or older at the time of delivery. The risk was higher among children of Asian or African descent. Perinatal factors had a higher impact on the risk of KD in children with Asian parents. Conclusion: Prematurity was significantly associated with an increased risk of developing KD. Other risks were prenatal maternal smoking, advanced maternal age, and being of Asian or African descent.
- Open Access
- 25 October 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (21) , e034248
Specific Morphology of Coronary Artery Aneurysms in Mainly White Patients With Kawasaki Disease: Initial Data From the Cardiac Catheterization in Kawasaki Disease Registry
Background: Patients with Kawasaki disease (KD) with coronary artery involvement require long‐term cardiac care. Although respective evidence‐based recommendations are missing, cardiac catheterization is still considered the gold standard for diagnosing detailed coronary pathology. Therefore, to better understand coronary artery pathology development, we conducted a survey to document and evaluate cardiac catheterization data in a European population. Methods and Results: We retrospectively analyzed cardiac catheterization data from KD children from the year 2010 until April 2023. This registry covers basic acute‐phase clinical data, and more importantly, detailed information on morphology, distribution, and the development of coronary artery pathologies. A total of 164 mainly White patients (65% boys) were included. A relevant number of patients had no coronary artery aneurysm (CAA) at the cardiac catheterization, indicating that distal CAAs were almost exclusively detected alongside proximal CAAs. Patients with multiple CAAs revealed a significant positive correlation between the number of CAAs and their dimensions in diameter and in length. Location of the CAA within the coronary artery, age at onset of KD, or natal sex did not significantly influence CAA diameters, but CAAs were longer in older children and in boys. Conclusions: That distal CAAs were only present together with proximal ones will hopefully reduce diagnostic CCs in patients with KD without echocardiographically detected proximal CAAs. Furthermore, this study gives valuable insights into dimensional specifics of CAAs in patients with KD. As an ongoing registry, future analyses will further explore long‐term outcomes and performed treatments, helping to refine clinical long‐term strategies for patients with KD. REGISTRATION: URL: https://drks.de/ ; Unique Identifier: DRKS00031022.
- 25 October 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (21) , e034248
Open AccessSpecific Morphology of Coronary Artery Aneurysms in Mainly White Patients With Kawasaki Disease: Initial Data From the Cardiac Catheterization in Kawasaki Disease Registry
Background: Patients with Kawasaki disease (KD) with coronary artery involvement require long‐term cardiac care. Although respective evidence‐based recommendations are missing, cardiac catheterization is still considered the gold standard for diagnosing detailed coronary pathology. Therefore, to better understand coronary artery pathology development, we conducted a survey to document and evaluate cardiac catheterization data in a European population. Methods and Results: We retrospectively analyzed cardiac catheterization data from KD children from the year 2010 until April 2023. This registry covers basic acute‐phase clinical data, and more importantly, detailed information on morphology, distribution, and the development of coronary artery pathologies. A total of 164 mainly White patients (65% boys) were included. A relevant number of patients had no coronary artery aneurysm (CAA) at the cardiac catheterization, indicating that distal CAAs were almost exclusively detected alongside proximal CAAs. Patients with multiple CAAs revealed a significant positive correlation between the number of CAAs and their dimensions in diameter and in length. Location of the CAA within the coronary artery, age at onset of KD, or natal sex did not significantly influence CAA diameters, but CAAs were longer in older children and in boys. Conclusions: That distal CAAs were only present together with proximal ones will hopefully reduce diagnostic CCs in patients with KD without echocardiographically detected proximal CAAs. Furthermore, this study gives valuable insights into dimensional specifics of CAAs in patients with KD. As an ongoing registry, future analyses will further explore long‐term outcomes and performed treatments, helping to refine clinical long‐term strategies for patients with KD. REGISTRATION: URL: https://drks.de/ ; Unique Identifier: DRKS00031022.